CMMI Institute Announces Inaugural Capability Creates 2026 Conference, Bringing Partners and Industry Leaders Together in Washington, D.C.

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Professionals across a range of industries looking to strengthen performance, quality, and operationalize AI in their environments will convene at CMMI Institute’s inaugural Capability Creates 2026 Conference in Washington, D.C., from June 23-24, 2026. The event will provide attendees with a unique opportunity to connect and learn about the latest CMMI updates, gain key insights into new initiatives and government efforts, understand alignment with CMMC, and be the first to hear pilot participant insights around the newly introduced CMMI Artificial Intelligence Maturity (AIM) framework.

The first-ever Capability Creates Conference will feature sessions on applying CMMI in government and across other industries, alignment with other frameworks and standards, real-world insights from CMMI adopters, using CMMI to navigate CMMC requirements, and the value CMMI AIM brings for managing AI risk, performance, data, and security.

Capability Creates 2026 offers two dedicated tracks suitable for industry attendees and CMMI Partners, with content tailored to their unique roles. The conference provides a once-a-year opportunity for business leaders to connect directly with CMMI Institute, CMMI Partners, and real-world adopters to turn proven practices into measurable business results. They can also hear from organizations using CMMI in live, complex environments and discover AI best practices they can deploy immediately.

This year’s conference features two keynote speakers—Matt Travis, CEO of Cyber AB, and Keisha Thomas, Director, Compliance and Quality at the FDA.

New AI Offering

At the conference, attendees will get a first look at the CMMI AI Maturity (AIM) framework—a practical model for operationalizing AI with stronger governance, clearer performance targets, and reduced risk. Through an inside view of the AIM pilot program, participants will leave with lessons learned and proven approaches that organizations are using now to improve AI reliability, strengthen security and data controls, accelerate compliant deployment, and deliver measurable business results.

“Capability Creates 2026 is where the community comes together to turn proven practices into performance—faster delivery, higher quality, and stronger risk management,” said Ron Lear, CMMI Institute Vice President, Global CMMI Strategies. “By bringing leaders together across sectors and geographies, we’re accelerating the adoption of best practices, introducing initiatives like AIM, and helping organizations translate AI process discipline into measurable outcomes.”

Additional Training

These two workshops will take place before and after the conference:

• Building Artificial Intelligence Maturity on Monday, June 22, 2026
• Appraising Artificial Intelligence Maturity | Thursday, June 25, 2026

The workshops are fully booked, but individuals interested in being put on a waitlist or registering for future sessions or course offerings can express interest here: https://survey.cmmiinstitute.com/667927?lang=en.

More Information

Registration for the in-person experience is priced at US$675 until the April 30 Early Bird deadline, then prices increase to US$795, and closes June 17.

For additional special rates, more details and registration, visit https://cmmiinstitute.com/conference.

About CMMI® Institute

CMMI® Institute is trusted by thousands of high-performing companies worldwide to deliver guidance to build and sustain processes that drive business value and innovation. CMMI (Capability Maturity Model Integration) is a globally recognized performance improvement framework that helps organizations elevate and benchmark their capabilities to deliver high-quality products and services. Backed by decades of proven results, CMMI empowers organizations across industries to achieve measurable outcomes in quality, productivity, and efficiency. Designed with an open architecture, CMMI adapts to emerging challenges and industry-specific needs—enabling the development of tailored extensions like the Medical Device Discovery Appraisal Program (MDDAP), which supports FDA’s Case for Quality initiative. To learn more about CMMI, visit www.cmmiinstitute.com.